A platform for research: civil engineering, architecture and urbanism
Casticin induced apoptotic cell death and altered associated gene expression in human colon cancer colo 205 cells
Casticin, a polymethoxyflavone, derived from natural plant Fructus Viticis exhibits biological activities including anti‐cancer characteristics. The anti‐cancer and alter gene expression of casticin on human colon cancer cells and the underlying mechanisms were investigated. Flow cytometric assay was used to measure viable cell, cell cycle and sub‐G1 phase, reactive oxygen species (ROS) and Ca2+ productions, level of mitochondria membrane potential (ΔΨm) and caspase activity. Western blotting assay was used to detect expression of protein level associated with cell death. Casticin induced cell morphological changes, decreased cell viability and induced G2/M phase arrest in colo 205 cells. Casticin increased ROS production but decreased the levels of ΔΨm, and Ca2+, increased caspase‐3, ‐8, and ‐9 activities. The cDNA microarray indicated that some of the cell cycle associated genes were down‐regulated such as cyclin‐dependent kinase inhibitor 1A (CDKN1A) (p21, Cip1) and p21 protein (Cdc42/Rac)‐activated kinase 3 (PAK3). TNF receptor‐associated protein 1 (TRAP1), CREB1 (cAMP responsive element binding protein 1) and cyclin‐dependent kinase inhibitor 1B (CDKN1B) (p27, Kip1) genes were increased but matrix metallopeptidase 2 (MMP‐2), toll‐like receptor 4 (TLR4), PRKAR2B (protein kinase, cAMP‐dependent, regulatory, type II, bet), and CaMK4 (calcium/calmodulin‐dependent protein kinase IV) genes were inhibited. Results suggest that casticin induced cell apoptosis via the activation of the caspase‐ and/or mitochondria‐dependent signaling cascade, the accumulation of ROS and altered associated gene expressions in colo 205 human colon cancer cells.
Casticin induced apoptotic cell death and altered associated gene expression in human colon cancer colo 205 cells
Casticin, a polymethoxyflavone, derived from natural plant Fructus Viticis exhibits biological activities including anti‐cancer characteristics. The anti‐cancer and alter gene expression of casticin on human colon cancer cells and the underlying mechanisms were investigated. Flow cytometric assay was used to measure viable cell, cell cycle and sub‐G1 phase, reactive oxygen species (ROS) and Ca2+ productions, level of mitochondria membrane potential (ΔΨm) and caspase activity. Western blotting assay was used to detect expression of protein level associated with cell death. Casticin induced cell morphological changes, decreased cell viability and induced G2/M phase arrest in colo 205 cells. Casticin increased ROS production but decreased the levels of ΔΨm, and Ca2+, increased caspase‐3, ‐8, and ‐9 activities. The cDNA microarray indicated that some of the cell cycle associated genes were down‐regulated such as cyclin‐dependent kinase inhibitor 1A (CDKN1A) (p21, Cip1) and p21 protein (Cdc42/Rac)‐activated kinase 3 (PAK3). TNF receptor‐associated protein 1 (TRAP1), CREB1 (cAMP responsive element binding protein 1) and cyclin‐dependent kinase inhibitor 1B (CDKN1B) (p27, Kip1) genes were increased but matrix metallopeptidase 2 (MMP‐2), toll‐like receptor 4 (TLR4), PRKAR2B (protein kinase, cAMP‐dependent, regulatory, type II, bet), and CaMK4 (calcium/calmodulin‐dependent protein kinase IV) genes were inhibited. Results suggest that casticin induced cell apoptosis via the activation of the caspase‐ and/or mitochondria‐dependent signaling cascade, the accumulation of ROS and altered associated gene expressions in colo 205 human colon cancer cells.
Casticin induced apoptotic cell death and altered associated gene expression in human colon cancer colo 205 cells
Shang, Hung‐Sheng (author) / Liu, Jia‐You (author) / Lu, Hsu‐Feng (author) / Chiang, Han‐Sun (author) / Lin, Chia‐Hain (author) / Chen, Ann (author) / Lin, Yuh‐Feng (author) / Chung, Jing‐Gung (author)
Environmental Toxicology ; 32 ; 2041-2052
2017-08-01
12 pages
Article (Journal)
Electronic Resource
English